Copolymer, undergoing trials, could improve fibrinolytics' effectiveness.
Raymond
C
C
D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D011060:Poloxalene / Q000627:therapeutic use*; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D013927:Thrombosis / Q000188:drug therapy*
D005343:Fibrinolytic Agents; D011092:Polyethylene Glycols; D011060:Poloxalene